Bone marrow neoplastic
Bone marrow - neoplastic myeloid
MDS / MPN
WHO-HAEM5 and ICC comparison - MDS / MPN
Author: Nikhil Sangle, M.D.
Last author update: 1 August 2011
Last staff update: 27 April 2023
Copyright: 2002-2023, PathologyOutlines.com, Inc.
PubMed Search: WHO classification MDS/MPN [title]
Table of Contents
Definition / general | World Health Organization classification | Additional referencesCite this page: Sangle N. WHO-HAEM5 and ICC comparison - MDS / MPN. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/myeloproliferativewhomdsmpnwho.html. Accessed June 1st, 2023.
Definition / general
- World Health Organization (WHO) classification of disorders which bridge the myelodysplastic (MDS) and myeloproliferative neoplasm (MPN) categories at initial presentation
- Have morphologic dysplasia and proliferative advantage of one or more of the myeloid differentiating cell lines
- Diagnosis requires correlation of bone marrow and peripheral blood findings with clinical, genetic and other laboratory information (Semin Diagn Pathol 2003;20:154)
World Health Organization classification
WHO 2008 classification
WHO 2001 classification
- 4.1 Chronic myelomonocytic leukemia
- 4.2 Juvenile myelomonocytic leukemia
- 4.3 Atypical chronic myeloid leukemia
- 4.4 MDS/MPN, unclassifiable
WHO 2001 classification
- Atypical chronic myeloid leukemia
- Chronic myelomonocytic leukemia
- Juvenile myelomonocytic leukemia
- Myelodysplastic / myeloproliferative disease, unclassifiable
Additional references
- WHO 2008: Leukemia 2008;22:14
- WHO 2001: Blood 2002;100:2292
